| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.647 | 1.877 | 2.813 | 1.956 | 248 | 137 | 0 | 0 | 0 |
| Total Income - EUR | - | 1.647 | 1.877 | 2.813 | 1.956 | 248 | 137 | 0 | 0 | 0 |
| Total Expenses - EUR | - | 221 | 289 | 241 | 140 | 195 | 352 | 235 | 234 | 242 |
| Gross Profit/Loss - EUR | - | 1.426 | 1.588 | 2.571 | 1.815 | 53 | -214 | -235 | -234 | -242 |
| Net Profit/Loss - EUR | - | 1.376 | 1.527 | 2.487 | 1.757 | 46 | -218 | -235 | -234 | -242 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - As Neuromedic Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 285 | 156 | 31 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 1.158 | 1.442 | 2.515 | 1.859 | 179 | 37 | 97 | 44 | 103 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 9 | 7 | 7 | 7 | 6 |
| Cash | - | 1.158 | 1.442 | 2.515 | 1.859 | 170 | 31 | 90 | 37 | 96 |
| Shareholders Funds | - | 1.421 | 1.580 | 2.539 | 1.807 | 96 | -125 | -360 | -593 | -832 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 23 | 18 | 7 | 52 | 83 | 162 | 456 | 637 | 935 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - As Neuromedic Srl